Kolexia
Wemeau Mathieu Hématologie
Wemeau Mathieu
Hématologie
Hôpital Huriez
Lille, France
84 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélofibrose primitive Polyglobulie Leucémies Syndromes myéloprolifératifs Lymphomes Myélome multiple Thrombose Polyglobulie primitive essentielle Leucémie aigüe myéloïde

Collaborateurs

Voir plus
Kiladjian Jean-Jacques
Kiladjian Jean-Jacques
Hôpital Saint-Louis, Paris, France
Plantier-Colcher Isabelle
Plantier-Colcher Isabelle
Centre Hospitalier de Roubaix, Roubaix, France
Dervite-Vaussoue Isabelle
Dervite-Vaussoue Isabelle
Centre Hospitalier de Roubaix, Roubaix, France
Ianotto Jean-Christophe
Ianotto Jean-Christophe
Hôpital Morvan, Brest, France

Industries

Voir plus
Novartis
47 collaboration(s)
Dernière en 2023
Abbvie
8 collaboration(s)
Dernière en 2023
Edimark
6 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
INDEPENDENCE: A Phase 3, Double-blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK Inhibitor Therapy and Who Require Red Blood Cell Transfusions
Essai Clinique (Celgene)   06 mars 2024
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Essai Clinique (Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH)   22 février 2024
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
Haematologica   08 février 2024
Involvement of the JAK-STAT Pathway in the Molecular Landscape of Fusion-Free Myeloid Neoplasms with Eosinophilia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Characterization of genetic variants in the gene identified in a European collection of patients with erythrocytosis.
Haematologica   01 novembre 2023
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Essai Clinique (CHU Brest)   27 octobre 2023
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice.
EJHaem   07 juin 2023
Ruxolitinib and risk of non-Hodgkin's lymphoma
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Thrombosis with Non-Proliferative Complete Blood Count Indicative of Underlying Myeloproliferative Neoplasm, Sythrom, a Study on Behalf of the FIM Group
Annual Meeting Abstracts 2022   15 novembre 2022
Gilteritinib Activity in Refractory or Relapsed FLT3-Mutated Acute Myeloid Leukemia Patients Previously Treated By Intensive Chemotherapy and Midostaurin: A Study from the French AML Intergroup ALFA/Filo
Annual Meeting Abstracts 2022   15 novembre 2022